Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pain × Acetaminophen × Clear all

Phase

Phase 4 5 Phase 3 3 Phase NA 2 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Lymphoma, Large B-Cell, Diffuse 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Trigger Finger Disorder 1 Sarcoma, Alveolar Soft Part 1 Renal Insufficiency 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Pain 1 Neoplasms, Plasma Cell 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Mucositis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Leukemia 1 Kidney Neoplasms 1 Infratentorial Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Diseases 1 Head and Neck Neoplasms 1

Interventions

Analgesia 6 Morphine 5 Pregabalin 3 Oxycodone 3 Fentanyl 3 ziconotide 2 nabiximols 2 Surveys and Questionnaires 2 Saline Solution 2 Radiofrequency Ablation 2 Methadone 2 Lidocaine 2 Ibandronic Acid 2 Duloxetine Hydrochloride 2 Docetaxel 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 tanezumab 1 tandutinib 1 siltuximab 1 resiniferatoxin 1 incobotulinumtoxinA 1 imisopasem manganese 1 fulranumab 1 erenumab 1 cyclobenzaprine 1 caffeine, sodium benzoate drug combination 1 Therapeutics 1 Tapentadol 1 Sulindac 1 Soybean Proteins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00712712 2025-08-29

MEDOR

Institut Bergonié

Phase 2 Completed

78 enrolled 28 charts

Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡